Finally, Alb-CTLA-4Ig may be a useful research tool to address the mechanisms of CTLA4Ig treatment and whether extranodal T cell activation contributes to the pathogeneses of autoimmune diseases. This evidence concerns the gene ALB and autoimmune disease.